Pascual, J., et al. CCNE1 mRNA and cyclin E1 protein expression as predictive biomarkers for efficacy of palbociclib plus fulvestrant versus capecitabine in the phase III PEARL study. J Clin Oncol 39, 2021 (suppl 15; abstr 1014) DOI: 10.1200/JCO.2021.39.15_suppl.1014
Johnson, K., et al. High-throughput detection of novel circulating miRNA biomarkers of non-alcoholic fatty liver disease. Litmus Project. Consortium Funded by the European Innovative Medicines Initiative.
Moura, D. S., et al. Immune-checkpoint genes as predictive biomarkers of trabectedin in advanced soft-tissue sarcoma (STS): A Spanish Group for Research on Sarcomas (GEIS) translational study. J Clin Oncol 38: 2020 (suppl; abstr 11546). DOI: 10.1200/JCO.2020.38.15_suppl.11546
Download jpg 6.0MB
View External Link
Naseem, M., et al. Variation in Genetic Polymorphisms and Gene Expression of HLA-E to Predict Outcomes in Metastatic Colorectal Cancer (mCRC) Patients (pts) Treated with First-line FOLFIRI/Cetuximab: Data from the Phase III FIRE-3 Trial. Poster session presented at Gastrointestinal Cancers Symposium. 2020 Jan 25. San Francisco, CA. J Clin Oncol 38, 2020 (suppl 4; abstr 245)
Battaglin, F., et al. Genetic variants in R-Spondin/RNF43 complex and gene expression levels to predict efficacy of cetuximab (cet) in patients (pts) with metastatic colorectal cancer (mCRC): Data from the FIRE-3 phase III trial. Poster session Clin Oncol 38, 2020 (suppl 4; abstr 190) presented at 2020 Gastrointestinal Cancers Symposium; 2020 Jan 25; San Francisco, CA.
Mehdi, M. et al., A drug-induced remission signature promises personalized therapy in RA patients. Poster session presented at: European Congress of Rheumatology; 2019 Jun 12-15; Madrid, Spain
Hurwitz, M. E., et al. Baseline tumor-immune signatures associated with response to bempegaldesleukin (NKTR-214) and nivolumab. Poster session presented at: American Society of Clinical Oncology (ASCO) Annual Meeting; June 1, 2019, Chicago, IL
Srour, M. et al. Gene expression comparison between primary triple-negative breast cancer and matched axillary lymph node metastasis. Poster session presented at: American Society of Clinical Oncology (ASCO) Annual Meeting; 2019 Jun 2, Chicago, IL.
Download pdf 1.2MB
View External Link
Richter, J. et al. Molecular Characteristics of Diffuse Large B-Cell Lymphoma and Correlation with Baseline Metabolic Tumor Volume (MTV), Interim Positron Emission Tomography (iPET) and Outcome in the PETAL Trial. Poster Presented at: ASH Annual meeting session 626. 2018 Dec 3. San Diego, CA
Download pdf 1.1MB
View External Link
Sarihan, E., et al. A biologic basis for locoregional failure in patients with oral cavity cancers. Poster #3681 Presented at: American Association for Cancer Research (AACR); 2018 Apr 14-18; Chicago, IL
Wistuba, I., et al, Gene expression difference (GED) revealed immune function gene down-regulation as tumor-associated inflammatory cell (TAIC) infiltration in microenvironment in non-small cell lung cancer (NSCLC). Poster#4054 Presented at American Association for Cancer Research (AACR) Annual Meeting; 2018 Apr 14-18; Chicago, IL
Download ppt 1.9MB
View External Link
Koshkin, V. S., et al. Prognostic value of CD56, ASCL1, and other biomarkers in small cell bladder cancer (SCBC). Poster session presented at: 2018 Genitourinary Cancers Symposium; 2018 Feb 9; San Francisco, CA. J Clin Oncol 36, 2018 (suppl 6S; abstr 452).
Page last updated May 22, 2023